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Tea tree oil (TTO), the essential oil of Melaleuca alternifolia L., is one of the most popular
agents used in cosmetics. This study aimed to explore the correlations of components in
TTO with its anti-acne activities and skin irritation. TTOs were isolated from the leaves
(TTO-L), twigs, and branches of M. alternifolia by steam distillation, and the components
analyzed by gas chromatographyemass spectrometry. Results showed that components of
TTO-L satisfied the International Organization for Standardization (ISO) 4730 guidelines.
TTO-L and its components, terpinen-4-ol, terpinolene, a-terpinene, and a-terpineol, had
strong inhibitory activities against Propionibacterium acnes and Staphylococcus aureus.
Moreover, six TTO formulas (DF-TTO) were designed according to ISO 4730 guidelines by
adjusting the proportions of these four active components. All DF-TTO formulas showed a
positive correlation between terpinen-4-ol concentration and anti-P. acnes activity. In the
skin irritation assay, TTO-L, terpinen-4-ol, and 1,8-cineole did not cause significant skin
irritation at 2% per site. In conclusion, terpinen-4-ol is the major active component
responsible for TTO’s antibacterial efficacy, while minor components in TTO also
contributed to its efficacy. Moreover, we suggest that a concentration less than 5% is more
suitable and safer for treating acne than higher concentrations.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license.1. Introduction of acne, such as increased sebum production by overactive oilAcne is a common skin problem that usually appears during
adolescence, and most often manifests in the skin surface of
the face, neck, arms, and back. There are several main causes, College of Pharmacy, Ta
. Wang).
ministration, Taiwan. Publglands, blockage of skin pores by retention hyperkeratosis,
normal skin bacterial activities (Propionibacterium acnes and
Staphylococcus aureus), and inflammation. Among these four
reasons, the overactivation of P. acnes and S. aureus plays aipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan,
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 2 e Reference reviews of the antifungal activity of
TTO [10,11].
Fungal species % (v/v)
MIC MFC
Aspergillus niger 0.02 0.05
Candida species 0.03 0.05
C. albicans 0.25-0.5 e
C. glabrata 0.25-1 e
Madurella mycetomatis 0.25 e
MIC ¼ minimum inhibitory concentration; MFC ¼ minimum
fungicidal concentration.
Table 3 e Reference reviews of the antibacterial
properties of the components of TTO [9,13,15].
Component Bacterial species mg/mL (w/v)
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matory responses. Therapeutic treatment of bacterium-
induced acne is antibiotic application, such as neomycin,
tetracycline, and erythromycin. However, excessive use of
antibiotics can cause antibiotic resistance that poses a serious
threat to public health worldwide [1].
Alternative and complementary medicines have been
extensively investigated in recent years. Essential oils, a type of
plant secondary metabolites, have been evaluated for their
bioactivities and potential therapeutic uses, such as anticancer,
antimicrobial, and anti-inflammation [1e3]. The potential syn-
ergy of essential oilswith antibioticswas previously postulated,
with the aim of alleviating the burden of antimicrobial resis-
tance to conventional antimicrobials [4]. Among the different
types of essential oils, Australian tea tree oil (TTO), obtained
from Melaleuca alternifolia L. (Myrtaceae) [5], is one of the best-
known essential oils that is frequently used to treat skin,
airway, oral, and vaginal infections, or usedas an antiseptic and
disinfectant [6]. Many reports describing the broad spectrum of
TTO’s antibacterial and antifungal activities have been pub-
lished and are summarized in Tables 1 and 2 [7e12].
The main ingredients of TTO are terpene hydrocarbons,
such as monoterpenes, sesquiterpenes, and their associated
alcohols. Moreover, TTO is reported to contain more than 100
components. According to the International Organization for
Standardization (ISO) 4730 guidelines, the concentrations of
TTO and terpinen-4-ol should be more than 30%, while that of
1,8-cineole should be less than 15%. In addition, the antibac-
terial activities of the components have also been reported,
such as that of terpinen-4-ol, a well-studied antibacterial
component in TTO. The antibacterial activities are summarized
in Table 3 [9,13e15]. However, there are many differences
among experiments, such as in the methods (agar diffusion or
broth dilution), the performance units of the minimum inhib-
itory concentration (MIC), and in minimum bactericidal con-
centration (MBC) values (percentage ormg/mL). However, thereTable 1e Reference reviews of the antibacterial activity of
TTO [7e9,12].
Bacterial species % (v/v)
MIC MBC
Gram-positive
Actinomyces viscosus 0.6 >0.6
Bacillus cereus 0.3 e
Enterococcus faecalis >8 >8
Staphylococcus aureus 0.5 2
Staphylococcus marcescens 0.25 0.25
MRSA 0.5 8
Gram-negative
Acinetobacter baumannii 1 1
Fusobacterium nucleatum 0.06 0.06
Klebsiella pneumoniae 0.25 0.25
Pseudomonas aeruginosa 3 3
Mollicutes
Mycoplasma hominis 0.12 e
Mycoplasma fermentans 0.03 e
MIC ¼ minimum inhibitory concentration; MBC ¼ minimum
bactericidal concentration; MRSA ¼ methicillin-resistant Staphylo-
coccus aureus.is no systematic assessment method available to explore the
antibacterial effects of each component.
On the other hand, 1,8-cineole, an abundant component in
Eucalyptus polybractea, is also abundantly found in TTO. There
is evidence to show that when koalas are only fed with E.
polybractea, 1,8-cineole exerts a narcotic effect and results in
long periods of sleep [16,17]. However, with increased use of
TTO, safety concerns have increased. In Rutherford et al’s
study, 2320 patients who used a patch-test correlated with
TTO and skin irritations over a 5-year period at the Skin and
Cancer Foundation were retrospectively reviewed; the results
showed that 41 cases had positive reactions to TTO, giving a
prevalence of 1.8% [18]. In addition, many studies reported
that exposure to a high dose of TTO can cause significant skin
and mucous membrane irritation [19].MIC MBC
Terpinen-4-ol Streptococcus pyogenes (Gþ) 0.8 1.6
Streptococcus gordonii (Gþ) 0.1 0.2
MRSA 0.25 (%) 0.5 (%)
Fusobacterium nucleatum (Ge) 0.1 0.4
Prevotella intermedia (Ge) 0.2 0.4
Porphyromonas gingivalis (Ge) 0.1 0.4
1,8-Cineol Staphylococcus epidermidis (Gþ) 1.6 3.2
Pseudomonas aeruginosa (G) 0.25 e
Salmonella typhimurium (G) 0.25 e
a-Pinene Prevotella intermedia (Ge) 0.8 0.8
Porphylomonas gingivalis (Ge) 0.8 1.6
a-Terpineol Streptococcus gordonii (Gþ) 0.05 0.1
Fusobacterium nucleatum (Ge) 0.4 0.8
Prevotella intermedia (Ge) 0.2 0.4
Porphyromonas gingivalis (Ge) 0.2 0.8
Sabinene Streptococcus pyogenes (Gþ) 0.2 0.4
Streptococcus mutans (Gþ) 0.8 1.6
Streptococcus sanguinis (Gþ) 0.4 0.4
Streptococcus sobrinus (Gþ) 0.2 0.2
Streptococcus criceti (Gþ) 0.1 0.2
MIC ¼ minimum inhibitory concentration; MBC ¼ minimum
bactericidal concentration; G(þ) ¼ positive Gram staining;
G(e) ¼ negative Gram staining; MRSA ¼ methicillin-resistant
Staphylococcus aureus.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 9e1 7 6 171In this study, TTOs were obtained from M. alternifolia and
their compositions analyzed by gas chromatographyemass
spectrometry (GCeMS). The efficacies of the antibacterial ac-
tivities of TTO and each component were evaluated, and
safety was assayed by acute dermal toxicity and chronic liver
toxicity tests usingWistar rats. Newly designed TTO formulas
were used, in which the composition percentages of terpinen-
4-ol and 1,8-cineole were adjusted so that the correlations
between these two TTO components with TTO’s antibacterial
effects and skin irritation could be determined.2. Methods
2.1. General
Analytical-grade terpinen-4-ol (Fluka code 86477), g-terpinene
(Fluka code 86476), a-terpinene (Fluka code 86473), 1,8-cineole
(Fluka code 29210), terpinolene (Fluka code 86484), r-cymene
(Fluka code 30039), a-pinene (Aldrich code 14, 752-4), a-
terpineol (Aldrich code 43, 262-8), aromadendrene (Fluka code
11067), limonene (Fluka code 89188), sabinene (Fluka code
96573), and globulol (Fluka code 49070) were purchased from
Sigma-Aldrich (Milan, Italy). The bacterial culture equipment,
including an anaerobic atmosphere by MGC AnaeroPack-
Anaero and MGC AnaeroPack-Jar, were from Mitsubishi Gas
Chemical Company (Tokyo, Japan). Blood agar plates (BAPs),
BactoTM tryptic soy broth (TSB), and BactoTM tryptic soy agar
(TSA) were from Difco (Detroit, MI, USA).
2.2. Animals
The following animal experiment was conducted according to
the Ethical Regulations on Animal Research of Taipei Medical
University (approval no. LAC-95-0005). Female Wistar rats
(nulliparous and non-pregnant), aged 8e10 weeks and
weighing about 200e220 g, were bought from BioLASCO in
Taiwan. Rats weremaintained at 25 1Cwith food andwater
ad libitum and kept on a 12-hour light/dark cycle.
2.3. Preparation of TTO from M. alternifolia
M. alternifoliawas collected from theTaiwanSeed Improvement
and Propagation Station (TSIPS, Taichung, Taiwan). Voucher
specimens (MA-01) were identified and deposited in the TSIPS.
TTO was obtained through steam distillation of dried M. alter-
nifolia leaves (TTO-L), twigs (TTO-T), and branches (TTO-B) in a
Clevenger-type apparatus for 7 hours. Each distillate was parti-
tioned with ether and the ether layer was separated and evap-
orated todryness at roomtemperature to afforddifferentpart of
TTOs. All TTOswere stored at 4C until analysis.
2.4. Quality control of TTO by GCeMS
The experimental protocol of the quality control of all TTOs
was modified from our previous study [20]. All TTO sample
analyses were carried out on a gas chromatographer GC-2010
equipped with a GCeMS (GCMS-QP2010, Shimadzu, Tokyo,
Japan). A DB-5MS column (0.25 mm i.d.  30 m  0.25 mm film;
J&W Scientific, Folsom, CA, USA) was used with helium as thecarrier gas at a constant pressure of 73.0 kPa. The injection
temperature and ion source temperature were 300C and
200C, respectively. The GC oven temperature was pro-
grammed to be maintained at 50C for 3 minutes, raised to
250C at 20C/minutes, maintained for 5 minutes, raised to
300C, and maintained for 3 minutes. The mass range was
30e350 m⁄z. The mass spectra of the GCeMS chromatograms
were compared to the database of the NIST/EPA/NIH Mass
Spectral Library to identify possible components.2.5. Growth conditions of P. acnes and S. aureus
Strains of P. acnes (BCRC10723) and S. aureus (BCRC 10781) were
obtained from the Bioresource Collection and Research Center
(Hsinchu, Taiwan). P. acnes was cultured in BAP, BactoTM TSB,
and BactoTM TSA in an anaerobic atmosphere using MGC
AnaeroPack-Anaero andMGCAnaeroPack-Jar. After that, P. acnes
was tested by subculturing in BAP at 37C for 72 hours. S. aureus
was cultured in BactoTMTSB andBactoTMTSA,while the testwas
performed by subculturing in TSB at 37C for 24 hours.2.6. Agar well-diffusion test
The experimental protocol was modified from Cai et al [21].
TTOwas tested against P. acnes by determining theMIC values
by the agar well-diffusion method. Briefly, P. acnes was incu-
bated on BAP agar under anaerobic conditions. A freshly
grown culture was diluted with BactoTM TSB, and 10 mL of
prepared bacteria [4  108 colony-forming units (cfu)/mL] was
aseptically added to 90 mL of sterilized media (TSA) at 45C in
a water bath. The seeded agarmedia were immediatelymixed
and poured into a Petri dish. Sterilized stainless steel cylinders
(8 mm in diameter) were put on a Petri dish to create the
sample wells. TTO and different terpene samples were dis-
solved in jojoba oil and tested in 2-fold serial dilutions.
Different kinds of TTO samples, at dosages of 0e80%, were
added to the sample wells. In addition, another composition
of TTO (devised formula, DF) was designed, in which the
percentages of terpinen-4-ol and 1,8-cineole were adjusted to
test the antimicrobial activities. Jojoba oil and 10 U of peni-
cillin were used as the respective negative and positive con-
trols. Plates were incubated under anaerobic conditions at
37C for 24 hours until visible growth of the test microorgan-
isms was evident in the control plates. Inhibition zones in
millimeters (including the disc diameter) were measured. The
experiment was repeated in triplicate. Moreover, S. aureus
(5  107 cfu/mL) was seeded in agar media and immediately
mixed in a Petri dish. The experimental protocol was the same
as that described above with some modifications. The anti-
microbial activity was expressed as the diameter of the inhi-
bition zones against the test microorganisms as follows:
Antimicrobial activity ð%Þ ¼

diameter zone of sample
diameter zone of pencillin

 100
The MIC and MBC of TTO were determined by agar well-
diffusion test. An inoculation loop was used to collect bacteria
fromclearzoneonagarplate.The inoculation loopwasenriched
in TSB for 24 hours. At the end of the incubation, TSB were put
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 9e1 7 6172onto the surfaceofnutrientagarplatesand incubatedat 37C for
24 hours. The MBC was estimated as the least concentration of
the TTO where no visible growth was observed. The MIC was
estimated as the least concentration of the TTO where visible
growth was observed.
2.7. Skin irritation assay of TTO in Wistar rats
The acute primary irritation test was applied by following the
classic Draize test [22]. The potential toxicity of TTO was
evaluated from a single topical application on Wistar rats.
Twenty-four hours before the test, the backs of the rats were
shaved free of hair (2.5  2.5 cm at each site) and checked for
any abnormalities (integrity and allergies) the next day. The
foundation color of the skin was measured before the test. An
appropriate concentration of a variety of TTOs (50 mL for each
sample) was smeared onto the shaved back of eachWistar rat.
Each group consisted of five rats. The patcheswere secured for
a 4-hour exposure period and removed with distilled water.
After application of the TTOs for 24 and 48 hours, skin irrita-
tion was observed, and the extent of evident skin allergic re-
action was evaluated for each test animal. Levels of skin
irritation were quantified through the Draize score (Table 4).
2.8. Chronic liver toxicity of TTO-L in Wistar rats
The experimental protocol for liver toxicity was modified from
our previous study [23]. TTO-L (2%, 50 mL) was smeared on the
shaved back of threeWistar rats daily for 28 days. On days 0 and
28, rats were lightly anesthetized, blood was obtained through
the tailvein,andglutamine-oxaloacetic transaminase (GOT)and
glutamic-pyruvic transaminase (GPT) levels were simulta-
neously measured on a Fuji DRI-CHEM 3500i analyzer (Tokyo,
Japan).
2.9. Statistical analysis
Data are presented as the mean and standard deviation (SD).
Significance was calculated using Student’s t-test by SPSS
software. Differences were considered significant at p < 0.05.Table 4 e Draize scoring system in albino rats.
Symptom Irritation
reaction
Erythema and eschar formation
No erythema 0
Very slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate-to-severe erythema 3
Severe erythema (beet redness)
to slight eschar formation (injuries in depth)
4
Edema formation
No edema 0
Very slight edema (barely perceptible) 1
Slight edema (edges of site
well-defined by definite raising)
2
Moderate edema (site raised 1 mm) 3
Severe edema (site raised >1 mm
and extending beyond area of exposure)
43. Results
3.1. Composition of TTOs in different parts of M.
alternifolia
In the current study, TTO components were extracted from
various parts of M. alternifolia. M. alternifolia was divided into
three groups according to branch thickness (Table 5). As
shown in Table 5, TTOwas predominantly in the leaves rather
than the branches. The yields of TTO-L, TTO-T, and TTO-B
were 2.02%, 0.59%, and 0.01%, respectively. The percentage
compositions of components identified in the TTOs are shown
in Table 6. According to ISO 4730 guidelines, the percentage of
terpinen-4-ol should be >30.0% and that of 1,8-cineole <
15.0%. Results showed that only TTO-L complied with ISO
4730 specifications. The major components in TTO-L were
terpinen-4-ol (47.31%), g-terpinene (20.59%), and a-terpinene
(9.58%); the percentage of 1,8-cineole, another notable
component, was 1.71%.3.2. Antibacterial effects of TTO-L and TTO components
Firstly, TTO-L was dissolved and diluted with jojoba oil before
the test. The inhibition ratio of TTO-L is shown in Fig. 1. TTO-L
presented high susceptibility and significant and dose-
dependent antibacterial activities against P. acnes. In
S. aureus, TTO-L presented slight antibacterial activities. The
MIC andMBC of TTO-L were 0.625% and 1.25% against P. acnes,
and 1.25% and 2.5% against S. aureus, respectively.
The antibacterial effects of 12 terpene compounds against
the growth of P. acnes and S. aureus were evaluated at 80%
(Table 7). Among the components, terpinen-4-ol, a-terpinene,
1,8-cineole, r-cymene, a-pinene, a-terpineol, and limonene
exhibited notable antimicrobial activities against P. acnes.
Terpinen-4-ol and a-terpineol exerted the strongest antimi-
crobial activities against P. acnes with MICs of 2.5%. Both
a-terpinene and limonene showed moderate antibacterial
activities against P. acnes with MICs of 10%. 1,8-Cineole,
r-cymene, and a-pinene were less effective against P. acnes
with MICs of 50%. On the other hand, antibacterial properties
against S. aureus also exhibited a concentration-dependent
effect, while a-terpinolene and a-terpinene were the most
effective components. The order of the others was a-terpineol,
(þ)-a-pinene, terpinen-4-ol, g-terpinene, and aromadendrene.
According to Table 7, the antimicrobial activities of TTO
were attributed mainly to terpinen-4-ol, a-terpineol, a-terpi-
nolene, and a-terpinene. Hence, different formulas of TTO
were prepared in accordance with the antibacterial data and
ISO 4730 guidelines. Compositions of the six DFs are shown in
Table 8. The design strategy is described in the followingTable 5 e Diameter and tea tree oil yield of various parts
M. alternifolia.
Leaf Twig Branch
Diameter (cm) e < 0.3 0.3e0.7
Yield (%) 2.02 0.59 0.01
Table 6 e Composition of prepared and commercial TTO.
Component CAS no. Molecular weight (g/mol) Retention time (min) ISO 4730 range (%) Prepared TTO (%)
TTO-L TTO-T
Terpinen-4-ol 562-74-3 154.25 8.575 >30 47.31 39.09
g-Terpinene 99-85-4 136.1 7.292 10e28 20.59 6.71
a-Terpinene 99-86-5 136.1 6.724 5e13 9.58 1.01
1,8-Cineole 470-82-6 154.25 7.075 <15 1.71 ND
a-Terpinolene 586-62-9 136.1 6.936 1.5e5 2.96 1.45
r-Cymene 99-87-6 134.22 6.967 0.5e12 1.51 ND
(þ)-a-Pinene 80-56-8 136.1 5.842 1e6 1.96 1.70
a-Terpineol 98-55-5 154.25 8.692 1.5e8 3.02 ND
Aromadendrene 489-39-4 204.35 10.867 Tracee7 <0.1 3.34
(þ)-Limonene 5989-27-5 136.24 7.017 Tracee8 0.47 ND
Sabinene 3387-41-5 136.24 6.350 0.5e4 1.55 0.44
Globulol 489-41-8 222.37 11.810 Tracee3.5 0.26 1.38
TTO-L ¼ tea tree oil from leaves; TTO-T ¼ tea tree oil from twigs; ND ¼ not detected.
Table 7 e Antibacterial activity of terpenes from TTO-L
against P. acnes and S. aureus.a
Terpene P. acnes S. aureus
Diameter of
inhibition zone
(multiples of
MIC
(%)
Diameter of
inhibition zone
(multiples of
MIC
(%)
j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 9e1 7 6 173statement. First, the effective components of a-terpinene,
terpinolene, a-terpineol, and a-pinene were adjusted to the
maximum allowed ratios. Then, moderate antimicrobial in-
gredients such as g-terpinene, r-cymene, and limonene were
added to half of the amount. Components with small or
negligible concentrations, which presented no antibacterial
effect, were reduced to zero. Finally, because the ISO 4730
guidelines do not limit the maximum percentage of terpinen-
4-ol, the strongest antibacterial component, three different
percentages of terpinen-4-ol (30%, 40%, and 50%) were
designed. On the other hand, the percentage of 1,8-cineole
used was 3%.
As shown in Fig. 2, all DFs displayed significant and dose-
dependent antibacterial effects against P. acnes. Among
them, DF5 and DF6 presented the strongest antibacterial ac-
tivities with both MICs of 1.25%. Referring to the design rule,
the antibacterial activities of DF5 and DF6 could probably be
attributed to the high content of terpinen-4-ol (50%). However,
all DFs displayed lower antibacterial effects against S. aureus,
which were dose-dependent (10e40%). DF1 and DF2 showed
stronger antibacterial activities against S. aureus than the
others, because of the higher percentages of a-terpinolene and
a-terpinene, the most effective components against S. aureus.5 10 20 40
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Fig. 1 e Inhibition ratio of TTO-L against P. acnes and S.
aureus. Each test was performed in triplicate.3.3. Toxicity effects of TTO-L
The toxicity effects of TTO-L were evaluated by a skin irrita-
tion assay and liver function evaluation. TTO-L and twomajor
components, terpinen-4-ol and 1,8-cineole, were used to
evaluate skin toxicity by a single topical application. Firstly, no
significant erythema and edema were found at 0 hours. As
shown in Fig. 3A, well-defined erythema (level 2) and very
slight edema (level 1) were found in the TTO-L-treated group
at 10% per site for 24 hours. Even when the application time
increased to 48 hours, the erythema and edema levels did not
change. When the concentration was reduced to 5% per site,
the irritation was diminished. No skin irritation was observed
when the concentration was decreased to 2.5%. On the otherpenicillin) penicillin)
Terpinen-4-ol 0.73  0.01 2.5 0.50  0.03 25
g-Terpinene 0.00  0.00 e 0.39  0.02 50
a-Terpinene 0.45  0.02 10 1.00  0.02 6.25
1,8-Cineole 0.35  0.00 80 0.00  0.00 e
Terpinolene 0.00  0.00 e 1.03  0.03 6.25
r-Cymene 0.38  0.01 60 0.00  0.00 e
a-Pinene 0.35  0.01 60 0.52  0.06 30
a-Terpineol 0.69  0.01 2.5 0.73  0.06 10
Aromadendrene 0.00  0.00 e 0.27  0.02 50
Limonene 0.51  0.01 40 0.00  0.00 e
Sabinene 0.00  0.00 e 0.00  0.00 e
Globulol 0.00  0.00 e 0.00  0.00 e
Jojoba oil b 0.00  0.00 e 0.00  0.00 e
Penicillin c 1.00  0.00 1.00  0.01
a The results are presented as the average of three independent
experiments.
b jojoba oil was the negative control.
c penicillin was the positive control. MIC ¼ minimum inhibitory
concentration; e ¼ no antibacterial activity.
Table 8 e Composition of six devised TTO formulas.
Component Percentage of components (%)
DF1 DF2 DF3 DF4 DF5 DF6
Terpinen-4-ol 30.0 30.0 40.0 40.0 50.0 50.0
g-Terpinene 19.0 19.0 19.0 19.0 19.0 19.0
a-Terpinene 13.0 13.0 13.0 13.0 13.0 13.0
1,8-Cineole 3.0 0.0 3.0 0.0 3.0 0.0
Terpinolene 5.0 5.0 5.0 5.0 5.0 5.0
r-Cymene 2.5 2.5 2.5 2.5 2.5 2.5
a-Pinene 6.0 6.0 6.0 6.0 6.0 6.0
a-Terpineol 8.0 8.0 8.0 8.0 8.0 8.0
Limonene 1.5 1.5 1.5 1.5 1.5 1.5
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 9e1 7 6174hand, with different concentrations of terpinen-4-ol, no evi-
dence of erythema, edema, or any other skin reactions were
observed at 24 hours and 48 hours (Fig. 3B). However, slight
irritation from 1,8-cineole was found at 0.75% and 1.5% per
site for 24 hours (Fig. 3C).
According to the above results, TTO-L did not display sig-
nificant dermal toxicity when the concentration was
decreased to 2.5%. In this study, 2% TTO-Lwas applied daily to
Wistar rats and liver function was monitored through serum
GOT and GPT levels on days 0, 14, and 28. As shown in Fig. 4,
no significant change in GOT or GPT levels were found on days
14 and 28, indicating that 2% TTO-L did not have liver toxicity.A 
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Fig. 2 e Antibacterial effects of devised formulas of TTO-L
against different bacteria. Each test was performed in
triplicate. (A) P. acnes. (B) S. aureus.4. Discussion
Use of TTO, an important complementary and alternative
medicine, has widely increased in recent years. In the 18th
century, the aboriginals in northern Australia (New South
Wales) used TTO to treat coughs and minor skin diseases [7].
From the early 1990s, bioactivities of TTO were increasingly
published in the scientific literature, with most attention
focusedon itsantimicrobialactivity. Inourstudy,TTOpresented
dose-dependent inhibitory effects against the growth of P. acnes
and S. aureus, while the inhibitory effects against P. acnes were
stronger than thoseagainstS. aureus (Table7).Thesefindingsare
similar to those shown in Wilkinson and Cavanagh’s [24] and
Carsonet al’s [25] papers that TTOpresentedbetter antibacterial
activity toward anaerobic bacteria than aerobic bacteria. How-
ever, the main constituents of TTO that are active against the
growth of P. acnes and S. aureuswere not well studied.
In 1925, Penfold used phenol as a disinfectant standard to
compare the antibacterial activity of the components of TTO
and presented them as the Rideal-Walker (RW) coefficient.
The RW coefficient was defined as a ratio of the antibacterial
activity of a sample compared to the antibacterial activity of
phenol. RW coefficients of TTO and TTO components were as
follows: TTO (RW:11), cineole (RW:3.5), cymene (RW:8),
linalool (RW:13), terpinen-4-ol (RW:13.3), and terpineol
(RW:16) [26]. Based on the above reference, terpinen-4-ol and
a-terpineol are the main active ingredients in TTO. However,
no research paper has reported the antibacterial activities of
each component of TTO. This is the first study to evaluate the
antibacterial effects of the components of TTO according to
ISO 4730 guidelines. As shown in Table 7, we also found that
terpinen-4-ol and a-terpineol presented the strongest anti-
bacterial activities against P. acnes. On the other hand, terpi-
nolene, a-terpinene, and a-pinene, minor components in
TTO-L, also contributed strong antibacterial activities
against S. aureus. In treating acne, anti-inflammation also
plays a critical role [26,27]. Hart and colleagues found that
terpinen-4-ol, the richest component in TTO, was also a po-
tential anti-inflammatory component that suppressed the
production of tumor necrosis factor-a, interleukin (IL)-1b, IL-8,
IL-10 and prostaglandin E2 by lipopolysaccharide (LPS)-acti-
vated human peripheral blood monocytes for 40 hours [5].
Therefore, when TTO is used to treat acne, it not only inhibits
microbial growth but also suppresses the inflammatory
response.
ISO 4730 specifies the characteristics of 15 kinds of TTO
constituents to facilitate assessment of its quality. However,
whether ISO 4730 can facilitate assessment of antibacterial
activities is still unknown. As shown in Fig. 1, four commercial
TTOs were in compliance with ISO 4730 standards, and all of
these commercial TTOs displayed antibacterial activities.
However, there were still some differences in the antibacterial
activities among the compounds. Hence, we suggest that ISO
4730 is a good standard to evaluate the compositions of TTO
but not its bioactivity. Based on the above findings, six devised
TTO formulas were prepared by adjusting the proportions of
themain components of TTO, and thesewere used to evaluate
the antibacterial activities. Results showed that DF5 and DF6,
which contained the highest terpinen-4-ol levels, exhibited
Fig. 3 e Skin erythema and edema levels after applying various samples of different concentrations on Wistar rats.
(A) TTO-L: B [ 0.625%; , [ 1.25%;O [ 2.5%; A [ 5%; 7 [ 10%. (B) Terpinen-4-ol. (C) 1,8-Cineole. C [ 0.094%;
- [ 0.188%; : [ 0.375%; A [ 0.750%;; [ 1.500%.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 9e1 7 6 175the strongest antibacterial activities. On the other hand, DF1
and DF2 showed stronger antibacterial activities than the
others against S. aureus because of the higher percentages of
a-terpinolene and a-terpinene, themost effective components
against S. aureus (Fig. 2). However, compared to the prepared
TTO-L, none of the antibacterial activities of any DF was as
good as that of natural TTO-L.
With increasing reports of the therapeutic properties of
TTO, several toxicity review papers of TTO were published.
TTO produces many local adverse reactions, such as contactDay 0 Day 14 Day 28
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Fig. 4 e Serum GOT and GPT levels of Wistar rats after
applying TTO-L for 28 days. The concentration of TTO-L
was 2%, and each test was performed in triplicate.allergy, irritation, and dermatitis in humans. However, most
of the literature suggests that levels of allergy and skin irri-
tation can be reduced by diluting TTO [18,19,28]. In this study,
several diluted concentrations were used to test the acute
dermal toxicity of TTO. The results showed that skin irritation
was significantly reduced when TTO concentration was less
than 2.5%. The components in TTO that caused the skin irri-
tation were thus further explored. Terpinen-4-ol, the major
component in TTO, and 1,8-cineole, a limited component in
TTO, were tested to determine if they were the major reasons
for skin irritation. First, TTO caused significant skin irritation
at 5%, while themaximumpercentage of terpinen-4-ol in TTO
was 30%. Hence, the skin irritation effect of terpinen-4-ol was
evaluated at a concentration of 1.5% and was found not to
cause skin irritation (Fig. 3). No document describes possible
skin toxicity caused by terpinen-4-ol. On the other hand, the
main toxic component in TTO, 1,8-cineole, was also assessed
using the same concentration. As shown in Fig. 3C, 1,8-cineole
at a concentration of 1.5% raised mild skin irritation, but the
irritation was much alleviated when the concentration was
less than 0.375%. However, the percentage of 1,8-cineole is
regulated to below 18% in ISO 4730, while 0.375% 1,8-cineole is
much lower than this regulated percentage. When TTO is
applied to the face to treat acne, safety is an important issue.
In this study, 2% TTO-L, a non-irritating dose, was applied to
the rats’ shaved backs daily to evaluate the liver toxicity of
TTO-L. As shown in Fig. 4, 2% TTO-L did not significantly
elevate GOT or GPT levels when it was applied daily, indicating
that TTO-L did not produce liver toxicity.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 9e1 7 6176Taken together, the antibacterial efficacy and safety of TTO
for treating acnewere investigated in this study. In terms of its
antibacterial efficacy, TTO-L significantly decreased acne
formation via inhibiting the growth of acne-related bacteria, P.
acnes and S. aureus, and reducing acne-caused inflammation.
In addition, terpinen-4-ol, the major component in TTO-L,
was also the major active component in its antibacterial effi-
cacy, while minor components in TTO contributed to its effi-
cacy as well. A common suggestion is that TTO be used at less
than 10%. In conclusion, TTO and its components exhibited
good antibacterial efficacy, but in terms of safety, we suggest
that less than 5% is more suitable and safer for treating acne.
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